# Jeena Sikho Lifecare (NSE: JSLL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/JSLL · Pivot · prices to 21 Oct 2026

Jeena Sikho Lifecare (NSE: JSLL) closed at ₹360.90 on 21 Oct 2026. With a market capitalisation of ₹4,564 Cr, it ranks 830th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 20.7× trailing earnings, against a return on equity of 26.9% in FY23. Over the past year the share price has fallen 51.9%. Its 52-week range is ₹359.25 (21 Oct 2026) to ₹835.00 (7 Nov 2025); the last close is 56.8% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹216 Cr (+54.8% year on year) and net profit ₹45 Cr (+77.9%), on a consolidated basis. Promoters held 63.62% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹360.90 |
| Market cap | ₹4,564 Cr |
| P/E (trailing) | 20.7 |
| ROE | 26.9% (FY23) |
| ROCE | 35.6% (FY23) |
| Debt to equity | 0.01 |
| 52-week high | ₹835.00 (7 Nov 2025) |
| 52-week low | ₹359.25 (21 Oct 2026) |
| 1-year return | −51.9% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹216 Cr | +54.8% | ₹45 Cr | +77.9% | ₹3.63 |
| Q3 FY26 | ₹222 Cr | — | ₹67 Cr | — | ₹5.36 |
| Q2 FY26 | ₹190 Cr | — | ₹59 Cr | — | ₹4.73 |
| Q1 FY26 | ₹174 Cr | — | ₹51 Cr | — | ₹4.13 |
| Q4 FY25 | ₹139 Cr | — | ₹25 Cr | — | ₹2.04 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY23 | ₹205 Cr | ₹34 Cr |
| FY22 | ₹147 Cr | ₹11 Cr |
| FY12 | ₹147 Cr | ₹11 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 63.62%
- Foreign institutions: 4.78%
- Domestic institutions: 0.36%
- Non-institutions: 31.23%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Novartis India](https://app.pivotnow.in/stock/NOVARTIND) | ₹1,919.80 | ₹4,740 Cr | 50.9 | — |
| [Zota Health Care](https://app.pivotnow.in/stock/ZOTA) | ₹1,361.00 | ₹4,713 Cr | — | — |
| [RPG Life Sciences](https://app.pivotnow.in/stock/RPGLIFE) | ₹2,849.00 | ₹4,712 Cr | 40.9 | — |
| [Orchid Pharma](https://app.pivotnow.in/stock/ORCHPHARMA) | ₹891.00 | ₹4,519 Cr | 217.8 | — |
| [Gufic Biosciences](https://app.pivotnow.in/stock/GUFICBIO) | ₹404.00 | ₹4,051 Cr | 63.1 | — |
| [SMS Pharmaceuticals](https://app.pivotnow.in/stock/SMSPHARMA) | ₹432.55 | ₹4,051 Cr | 38.8 | — |

## Questions and answers

### What is the share price of Jeena Sikho Lifecare today?

Jeena Sikho Lifecare (NSE: JSLL) last closed at ₹360.90 on 21 Oct 2026. Its 52-week high is ₹835.00 and its 52-week low is ₹359.25.

### What is the market cap of Jeena Sikho Lifecare?

Jeena Sikho Lifecare's market capitalisation is ₹4,564 Cr (₹4,564 Cr) at the 19 Oct 2026 close, ranking 830th among the NSE companies Pivot tracks.

### What is the P/E ratio of Jeena Sikho Lifecare?

Jeena Sikho Lifecare trades at a trailing P/E of 20.7. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 50.9.

### What is the ROE and ROCE of Jeena Sikho Lifecare?

Return on equity was 26.9% in FY23 and return on capital employed was 35.6% in FY23 (consolidated figures).

### Is Jeena Sikho Lifecare a debt-free company?

Jeena Sikho Lifecare is close to debt-free: its debt-to-equity ratio was 0.01 in FY23.

### What were Jeena Sikho Lifecare's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Jeena Sikho Lifecare reported revenue of ₹216 Cr, +54.8% year on year, and net profit of ₹45 Cr, +77.9% year on year.

### How has Jeena Sikho Lifecare stock performed over the last year?

Jeena Sikho Lifecare's share price has fallen 51.9% over the past year, −35.9% over three months and −25.2% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Jeena Sikho Lifecare?

As of 30 Jun 2026: promoters 63.62%, foreign institutions 4.78%, domestic institutions 0.36%, non-institutions 31.23%.

### Who are Jeena Sikho Lifecare's competitors?

The listed Pharma & Healthcare companies closest to Jeena Sikho Lifecare by market cap are Novartis India, Zota Health Care, RPG Life Sciences, Orchid Pharma, Gufic Biosciences and SMS Pharmaceuticals.

### Is Jeena Sikho Lifecare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Jeena Sikho Lifecare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on JSLL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.